» Articles » PMID: 15752874

A Challenge to the Therapeutic Nihilism of ESPAC-1

Overview
Specialties Oncology
Radiology
Date 2005 Mar 9
PMID 15752874
Citations 23
Authors
Affiliations
Soon will be listed here.
Citing Articles

Perioperative Radiation for Patients with Resectable Pancreatic Cancer: an Updated Review After the Initial RTOG 0848 Results.

Kersch C, Grossberg A J Gastrointest Cancer. 2025; 56(1):70.

PMID: 39987276 DOI: 10.1007/s12029-025-01185-0.


Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy.

Franklin O, Sugawara T, Ross R, Franco S, Colborn K, Karam S Ann Surg Oncol. 2024; 31(8):4966-4975.

PMID: 38789615 DOI: 10.1245/s10434-024-15157-4.


Krüppel-like Factor 10 as a Prognostic and Predictive Biomarker of Radiotherapy in Pancreatic Adenocarcinoma.

Tsai Y, Hsin M, Liu R, Li T, Chang H Cancers (Basel). 2023; 15(21).

PMID: 37958386 PMC: 10648792. DOI: 10.3390/cancers15215212.


Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy.

Jan I, Chang H Radiat Oncol. 2023; 18(1):137.

PMID: 37596627 PMC: 10439654. DOI: 10.1186/s13014-023-02328-y.


Impact of Adjuvant Chemoradiotherapy on Survival of Resected Pancreatic Adenocarcinoma Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis.

Shi X, Peng J, Jiang H, Gao Y, Wang W, Zhou F Front Oncol. 2021; 11:651671.

PMID: 34277405 PMC: 8281351. DOI: 10.3389/fonc.2021.651671.